FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sodium Iodide I 131 Solution
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism; Oncology

Expand all

Mallinckrodt Nuclear Medicine LLC (New 05/03/2018)

Company Contact Information:
314-595-3700

Presentation Posting Date Related Information
1 mL Solution ; 185 MBq (5 mCi)(NDC 69945-450-01) 05/03/2018 Mallinckrodt Nuclear Medicine/Curium has decided to discontinue the Sodium Iodide I 131 drug products for business reasons.
2 mL Solution ; 370 MBq (10 mCi)(NDC 69945-450-02) 05/03/2018 Mallinckrodt Nuclear Medicine/Curium has decided to discontinue the Sodium Iodide I 131 drug products for business reasons.
3 mL Solution; 555 MBq (15 mCi)(NDC 69945-450-03) 05/03/2018 Mallinckrodt Nuclear Medicine/Curium has decided to discontinue the Sodium Iodide I 131 drug products for business reasons.
4 mL Solution; 740 MBq (20 mCi)(NDC 69945-450-04) 05/03/2018 Mallinckrodt Nuclear Medicine/Curium has decided to discontinue the Sodium Iodide I 131 drug products for business reasons.
5 mL Solution ; 925 MBq (25 mCi)(NDC 69945-450-05) 05/03/2018 Mallinckrodt Nuclear Medicine/Curium has decided to discontinue the Sodium Iodide I 131 drug products for business reasons.
7 mL Solution ; 1295 MBq (35 mCi)(NDC 69945-450-07) 05/03/2018 Mallinckrodt Nuclear Medicine/Curium has decided to discontinue the Sodium Iodide I 131 drug products for business reasons.
2 mL Solution ; 1850 MBq (50 mCi)(NDC 69945-451-02) 05/03/2018 Mallinckrodt Nuclear Medicine/Curium has decided to discontinue the Sodium Iodide I 131 drug products for business reasons.
3 mL Solution; 2775 MBq (75 mCi)(NDC 69945-451-03) 05/03/2018 Mallinckrodt Nuclear Medicine/Curium has decided to discontinue the Sodium Iodide I 131 drug products for business reasons.
4 mL Solution; 3700 MBq (100 mCi)(NDC 69945-451-04 ) 05/03/2018 Mallinckrodt Nuclear Medicine/Curium has decided to discontinue the Sodium Iodide I 131 drug products for business reasons.
6 mL Solution; 5550 MBq (150 mCi)(NDC 69945-451-06) 05/03/2018 Mallinckrodt Nuclear Medicine/Curium has decided to discontinue the Sodium Iodide I 131 drug products for business reasons.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English